Your browser is no longer supported. Please, upgrade your browser.
Settings
NDRA ENDRA Life Sciences Inc. daily Stock Chart
NDRA [NASD]
ENDRA Life Sciences Inc.
Index- P/E- EPS (ttm)-2.13 Insider Own3.17% Shs Outstand4.33M Perf Week-8.15%
Market Cap9.27M Forward P/E- EPS next Y- Insider Trans- Shs Float3.80M Perf Month-11.76%
Income-7.50M PEG- EPS next Q- Inst Own12.80% Short Float2.39% Perf Quarter-11.57%
Sales0.40M P/S23.17 EPS this Y-155.80% Inst Trans- Short Ratio0.79 Perf Half Y-30.74%
Book/sh0.72 P/B2.97 EPS next Y- ROA-118.20% Target Price- Perf Year-
Cash/sh0.72 P/C2.99 EPS next 5Y- ROE-129.40% 52W Range1.55 - 5.88 Perf YTD-55.97%
Dividend- P/FCF- EPS past 5Y- ROI-87.30% 52W High-63.61% Beta-
Dividend %- Quick Ratio3.70 Sales past 5Y- Gross Margin51.70% 52W Low38.06% ATR0.39
Employees5 Current Ratio4.00 Sales Q/Q- Oper. Margin- RSI (14)45.81 Volatility18.69% 17.34%
OptionableNo Debt/Eq0.00 EPS Q/Q-279.40% Profit Margin- Rel Volume0.23 Prev Close2.09
ShortableNo LT Debt/Eq0.00 Earnings- Payout- Avg Volume115.78K Price2.14
Recom- SMA20-12.20% SMA50-3.37% SMA200-25.98% Volume27,104 Change2.39%
Jul-12-18 08:31AM  ENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS Technology ACCESSWIRE
Jul-02-18 08:31AM  ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants ACCESSWIRE
Jun-05-18 08:30AM  ENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +11.67%
May-24-18 04:19PM  Should You Worry About ENDRA Life Sciences Incs (NASDAQ:NDRA) CEO Pay Check? Simply Wall St.
May-15-18 04:01PM  ENDRA Life Sciences Reports First Quarter 2018 Financial Results ACCESSWIRE -15.52%
Apr-26-18 08:31AM  ENDRA Life Sciences to Host First Quarter 2018 Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET ACCESSWIRE
Apr-09-18 08:31AM  ENDRA Life Sciences to Showcase Photoacoustic Imaging Technology at American Association for Cancer Research (AACR) Annual Meeting on April 14-18 in Chicago ACCESSWIRE +10.38%
Apr-02-18 10:30AM  ENDRA Life Sciences to Present at The MicroCap Conference on Tuesday, April 10, 2018 ACCESSWIRE
Mar-20-18 04:01PM  ENDRA Life Sciences Reports Fourth Quarter and Full Year 2017 Financial Results ACCESSWIRE
Mar-08-18 12:59PM  ENDRA Life Sciences Inc (NASDAQ:NDRA): Does The -48.17% Earnings Decline Make It An Underperformer? Simply Wall St.
Mar-07-18 08:31AM  ENDRA Life Sciences to Host Fourth Quarter and Full Year 2017 Results Conference Call on Tuesday, March 20, 2018 at 4:30 p.m. ET ACCESSWIRE
Feb-27-18 08:31AM  ENDRA Life Sciences to Present at the Inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 5:00 p.m. ET ACCESSWIRE
Feb-15-18 08:31AM  ENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +6.13%
Feb-05-18 08:31AM  ENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRA's TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Dec-27-17 05:25PM  Who Are The Top Investors In ENDRA Life Sciences Inc (NASDAQ:NDRA)? Simply Wall St.
Dec-08-17 06:33PM  What Did ENDRA Life Sciences Incs (NDRA) CEO Take Home Last Year? Simply Wall St. -7.94%
Nov-30-17 03:45PM  How ENDRA Life Sciences Incs (NDRA) EPS Dropped 45.2%, Did Its Industry Show Weakness Too? Simply Wall St.
Nov-22-17 08:31AM  ENDRA Life Sciences to Present at the 10th Annual LD Micro Main Event on December 6, 2017 ACCESSWIRE +11.72%
Nov-15-17 08:31AM  ENDRA Life Sciences Reports Third Quarter 2017 Financial Results ACCESSWIRE
08:17AM  Should Your Next Investment In The Healthcare Industry Be In ENDRA Life Sciences Inc (NDRA)? Simply Wall St.
Nov-08-17 09:22AM  ENDRA Life Sciences Contracts The Centre for Imaging Technology Commercialization (CIMTEC) to Initiate Human Studies with ENDRA's Clinical TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Nov-02-17 08:31AM  ENDRA Life Sciences Partners with StarFish Medical and CriTech Research to Commence Development of TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Oct-23-17 08:31AM  ENDRA Life Sciences to Host Third Quarter 2017 Results Conference Call on Wednesday, November 15, 2017 at 4:30 p.m. ET ACCESSWIRE
Sep-28-17 08:31AM  ENDRA Life Sciences Completes Delivery and Installation of its Next Generation Nexus 128+ to Leading Research University in South Korea ACCESSWIRE
Sep-27-17 08:31AM  ENDRA Life Sciences to Participate at Upcoming Investor Conferences ACCESSWIRE
Sep-07-17 08:31AM  ENDRA Life Sciences to Participate at Upcoming Investor Conferences ACCESSWIRE -7.69%
Sep-06-17 08:31AM  ENDRA Life Sciences to Present New Photoacoustic Imaging Research at the 2017 World Molecular Imaging Congress on September 16, 2017 ACCESSWIRE
Aug-08-17 08:31AM  ENDRA Life Sciences Reports Second Quarter 2017 Financial Results ACCESSWIRE -11.14%
Jul-06-17 10:00AM  ENDRA Life Sciences Inc. (NASDAQ: NDRA) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.